Outcomes of Cyanoacrylate Tissue Adhesive Application in Corneal Thinning and Perforation

Overview

Journal Cornea

Specialty Ophthalmology

Date 2019 Mar 14

PMID 30865049

Citations 24

Authors

Jia Yin

Rohan Bir Singh

Rani Al Karmi

Ann Yung

Man Yu

Reza Dana

Affiliations

Soon will be listed here.

Abstract

Purpose: To report the outcomes of cyanoacrylate tissue adhesive (CTA) application in corneal thinning and perforation.

Methods: A retrospective interventional case series of 137 patients receiving CTA for corneal thinning and perforation in 140 eyes between 2001 and 2018 at a single center was reviewed. Success rate and factors associated with glue failure were analyzed.

Results: Median age of the cohort was 63 years and 69 (50%) were women. One hundred fifteen patients (84%) had at least 1 systemic condition, 46 (34%) had autoimmune diseases. Eighty-nine eyes (64%) presented with perforation and 51 (36%) with thinning. The perforation/thinning was central/paracentral in 82 eyes (59%) and peripheral in 57 eyes (41%). Median size of perforation was 3.1 mm. Causes of perforation and thinning were microbial infection in 75 (55%), sterile melt in 49 (35%), laceration in 10, and keratoprosthesis melt in 8 eyes. Median glue retention was 58 days. Success rate of glue application (defined as intact globe without surgical intervention) was 72%, 61%, and 46% at 10, 30, and 90 days after glue application, respectively. Larger size of perforation/thinning, perforation (vs. thinning), and single glue application (vs. multiple) were correlated with higher failure rate. Systemic conditions, use of topical corticosteroid, etiologies, and location of perforation/thinning were not significantly correlated with glue failure.

Conclusions: CTA application was moderately effective in stabilizing corneal perforation and thinning in the very short-term. Multiple applications are often required. Maintenance of globe integrity after glue application decreases with time and the need for surgical intervention remains high.

Citing Articles

Divergence in photoreceptor cell death and neuroinflammation in transvitreal and transscleral subretinal delivery in mice.

Maidana D, Puente S, Wang C, Chandra S, Gonzalez-Buendia L, Ilios E J Inflamm (Lond). 2025; 22(1):5.

PMID: 39920719 PMC: 11806547. DOI: 10.1186/s12950-025-00433-1.

Kuragel: A biomimetic hydrogel scaffold designed to promote corneal regeneration.

Agrawal P, Tiwari A, Chowdhury S, Vohra M, Gour A, Waghmare N iScience. 2024; 27(5):109641.

PMID: 38646166 PMC: 11031829. DOI: 10.1016/j.isci.2024.109641.

Inflammation-suppressing cornea-in-a-syringe with anti-viral GF19 peptide promotes regeneration in HSV-1 infected rabbit corneas.

Simoliunas E, Ruedas-Torres I, Jimenez-Gomez Y, Edin E, Aghajanzadeh-Kiyaseh M, Zamani-Roudbaraki M NPJ Regen Med. 2024; 9(1):11.

PMID: 38429307 PMC: 10907611. DOI: 10.1038/s41536-024-00355-1.

Freeze-dried amniotic membrane graft with a spongy layer in bilateral peripheral ulcerative keratitis: a case report.

Bertret C, Leveziel L, Knoeri J, Georgeon C, Jamart C, Bouheraoua N BMC Ophthalmol. 2023; 23(1):387.

PMID: 37735358 PMC: 10515264. DOI: 10.1186/s12886-023-03129-3.

Outcomes of N-butyl-2-Cyanoacrylate Tissue Adhesive Application in Corneal Perforation Disorders: Consecutive Case Series.

Sadiq S, Cartes C, Sarfraz M, Figueiredo F Ophthalmol Ther. 2023; 12(6):3403-3413.

PMID: 37589930 PMC: 10640518. DOI: 10.1007/s40123-023-00785-y.

References

Lekskul M, Fracht H, Cohen E, Rapuano C, Laibson P . Nontraumatic corneal perforation. Cornea. 2000; 19(3):313-9. DOI: 10.1097/00003226-200005000-00011. View

Sharma A, Kaur R, Kumar S, Gupta P, Pandav S, Patnaik B . Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology. 2003; 110(2):291-8. DOI: 10.1016/S0161-6420(02)01558-0. View

Garg P, Gopinathan U, Nutheti R, Rao G . Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea. 2003; 22(5):405-8. DOI: 10.1097/00003226-200307000-00003. View

Holladay J . Visual acuity measurements. J Cataract Refract Surg. 2004; 30(2):287-90. DOI: 10.1016/j.jcrs.2004.01.014. View

de Almeida Manzano R, Naufal S, Hida R, Guarnieri L, Nishiwaki-Dantas M . Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens. Cornea. 2006; 25(3):350-1. DOI: 10.1097/01.ico.0000183490.16131.e3. View

Bhatia S . Ocular surface sealants and adhesives. Ocul Surf. 2006; 4(3):146-54. DOI: 10.1016/s1542-0124(12)70041-1. View

Chen W, Lin C, Hsieh C, Tu I, Chen W, Hu F . Comparison of the bacteriostatic effects, corneal cytotoxicity, and the ability to seal corneal incisions among three different tissue adhesives. Cornea. 2007; 26(10):1228-34. DOI: 10.1097/ICO.0b013e3181506129. View

Mattamal G . US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives. Expert Rev Med Devices. 2007; 5(1):41-9. DOI: 10.1586/17434440.5.1.41. View

Cavanaugh T, Gottsch J . Infectious keratitis and cyanoacrylate adhesive. Am J Ophthalmol. 1991; 111(4):466-72. DOI: 10.1016/s0002-9394(14)72382-7. View

10.

Moorthy S, Jhanji V, Constantinou M, Beltz J, Graue-Hernandez E, Vajpayee R . Clinical experience with N-butyl cyanoacrylate tissue adhesive in corneal perforations secondary to herpetic keratitis. Cornea. 2010; 29(9):971-5. DOI: 10.1097/ICO.0b013e3181cbfa13. View

11.

Khalifa Y, Bailony M, Bloomer M, Killingsworth D, Jeng B . Management of nontraumatic corneal perforation with tectonic drape patch and cyanoacrylate glue. Cornea. 2010; 29(10):1173-5. DOI: 10.1097/ICO.0b013e3181d5d996. View

12.

Sharma A, Mohan K, Nirankari V . Management of nontraumatic corneal perforation with tectonic drape patch and cyanoacrylate glue. Cornea. 2011; 31(4):465-6. DOI: 10.1097/ICO.0b013e31821de358. View

13.

Jhanji V, Young A, Mehta J, Sharma N, Agarwal T, Vajpayee R . Management of corneal perforation. Surv Ophthalmol. 2011; 56(6):522-38. DOI: 10.1016/j.survophthal.2011.06.003. View

14.

Gandhewar J, Savant V, Prydal J, Dua H . Double drape tectonic patch with cyanoacrylate glue in the management of corneal perforation with iris incarceration. Cornea. 2013; 32(5):e137-8. DOI: 10.1097/ICO.0b013e3182801809. View

15.

Rana M, Savant V . A brief review of techniques used to seal corneal perforation using cyanoacrylate tissue adhesive. Cont Lens Anterior Eye. 2013; 36(4):156-8. DOI: 10.1016/j.clae.2013.03.006. View

16.

Prajna N, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M . The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013; 131(4):422-9. PMC: 3769211. DOI: 10.1001/jamaophthalmol.2013.1497. View

17.

Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, OBrien K . The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. Am J Ophthalmol. 2013; 157(2):327-333.e3. PMC: 3946996. DOI: 10.1016/j.ajo.2013.09.025. View

18.

Tan J, Wechsler A, Watson S . Long-term adhesion of cyanoacrylate on human cornea. Clin Exp Ophthalmol. 2014; 42(8):791-3. DOI: 10.1111/ceo.12300. View

19.

Singh J, Saag K, Bridges Jr S, Akl E, Bannuru R, Sullivan M . 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015; 68(1):1-25. DOI: 10.1002/acr.22783. View

20.

Portnoy S, Insler M, Kaufman H . Surgical management of corneal ulceration and perforation. Surv Ophthalmol. 1989; 34(1):47-58. DOI: 10.1016/0039-6257(89)90129-x. View